ZYME Q2 2021 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-85.7% YoY

Gross Profit

-$49M-2763.4% margin

Operating Income

-$69M-3889.6% margin

Net Income

-$68M-3812.6% margin

EPS (Diluted)

$-1.31

QoQ Revenue Growth

+175.0%

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$52M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$472M

Total Liabilities

$150M

Stockholders' Equity

$321M

Cash & Equivalents

$257M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$12M	-85.7%
Gross Profit	-$49M	-$27M	-82.2%
Operating Income	-$69M	-$40M	-70.7%
Net Income	-$68M	-$39M	-73.3%

Revenue Segments

Other Product

$2M100%